Harvard Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HBIO and other ETFs, options, and stocks.

About HBIO

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. 

CEO
John D. Duke
CEOJohn D. Duke
Employees
339
Employees339
Headquarters
Holliston, Massachusetts
HeadquartersHolliston, Massachusetts
Founded
1901
Founded1901
Employees
339
Employees339

HBIO Key Statistics

Market cap
21.65M
Market cap21.65M
Price-Earnings ratio
-0.38
Price-Earnings ratio-0.38
Dividend yield
Dividend yield
Average volume
68.71K
Average volume68.71K
High today
$5.10
High today$5.10
Low today
$4.72
Low today$4.72
Open price
$4.95
Open price$4.95
Volume
42.93K
Volume42.93K
52 Week high
$9.46
52 Week high$9.46
52 Week low
$2.81
52 Week low$2.81

Stock Snapshot

The current Harvard Bioscience(HBIO) stock price is $4.84, with a market capitalization of 21.65M. The stock trades at a price-to-earnings (P/E) ratio of -0.38.

On 2026-03-18, Harvard Bioscience(HBIO) stock moved within a range of $4.72 to $5.10. With shares now at $4.84, the stock is trading +2.6% above its intraday low and -5.1% below the session's peak.

Trading activity shows a volume of 42.93K, compared to an average daily volume of 68.71K.

The stock's 52-week range extends from a low of $2.81 to a high of $9.46.

The stock's 52-week range extends from a low of $2.81 to a high of $9.46.

HBIO News

TipRanks 17h
Harvard Bioscience CEO Makes Bold Insider Move With Fresh Stock Purchase

New insider activity at Harvard Bioscience ( (HBIO) ) has taken place on March 17, 2026. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerfu...

TipRanks 1d
Harvard Bioscience Highlights CFO Appointment and Strategic Repositioning

Harvard Bioscience ( (HBIO) ) just unveiled an update. In its latest investor presentation dated March 2026, Harvard Bioscience outlines recent strategic and f...

TipRanks 2d
Harvard Bioscience price target adjusted to $6 at Benchmark after reverse split

Benchmark analyst Bruce Jackson raised the firm’s price target on Harvard Bioscience (HBIO) to $6 from 60c and keeps a Speculative Buy rating on the shares afte...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.